Home › Sosei Subsidiary Heptares Awarded $5.5M Research & Development Grant From The US National Institute On Drug Abuse
 

Keywords :   


Sosei Subsidiary Heptares Awarded $5.5M Research & Development Grant From The US National Institute On Drug Abuse

2015-09-30 08:19:49| drugdiscoveryonline News Articles

Sosei Group Corporation is pleased to announce that its wholly-owned subsidiary Heptares Therapeutics (“Heptares”) has been awarded a grant from the National Institute on Drug Abuse (NIDA), one of the US National Institutes of Health

Tags: research development national abuse

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »